Updated on 9 September 2026
Three proprietary actives from fermentation, looking for formulators and distributors
General Manager at BiCT srl
Lodi, Italy
About
Three actives developed and produced by BiCT. Lactive is a patented bioactivated lactoferrin, up to twenty times more active than the intact protein, with peptides small enough to penetrate the skin; it covers acne-prone skin, anti-age, atopic skin, scalp, oral and intimate care, and has two clinical trials behind it. Evobiom is a postbiotic from a documented Lacticaseibacillus rhamnosus strain, characterised by exometabolomics with the University of Bari: same INCI as others on the market, different content, with a declared strain rather than an anonymous one. ExoLife Rh is extracellular vesicles from precision fermentation, working on barrier, microcirculation and skin tone, effective from 0.1% to 1%. Distribution is already active in Italy, Spain, Poland, India, China, South Korea, New Zealand and the Philippines. Samples and technical packages on request, under confidentiality.
Similar opportunities
Project cooperation
Looking for consortium partners for bioeconomy and industrial biotechnology calls
Silvia Rapacioli
General Manager at BiCT srl
Lodi, Italy
Partnership
Contract R&D in industrial biotechnology: from strain development to pilot batch
Silvia Rapacioli
General Manager at BiCT srl
Lodi, Italy
Partnership
In vitro safety and efficacy testing for finished cosmetics and substance-based medical devices
Silvia Rapacioli
General Manager at BiCT srl
Lodi, Italy